Net profit of Senores Pharmaceuticals rose 84.28% to Rs 31.66 crore in the quarter ended December 2025 as against Rs 17.18 crore during the previous quarter ended December 2024. Sales rose 60.02% to Rs 164.85 crore in the quarter ended December 2025 as against Rs 103.02 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 164.85 | 103.02 | 60 |
| OPM % | 32.76 | 24.94 | - |
| PBDT | 52.46 | 24.69 | 112 |
| PBT | 44.60 | 20.49 | 118 |
| NP | 31.66 | 17.18 | 84 |